GlassScriptPhysician profile
Jocybel Itorralba
NPI 1184274037
$2,566.30
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,566.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $921.83 | 2021 | |
| Abbvie INC. | $346.42 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $230.90 | 2021 | |
| Janssen Pharmaceuticals, INC | $203.16 | 2021 | |
| Novo Nordisk INC | $148.26 | 2021 | |
| Nestle Healthcare Nutrition INC. | $143.86 | 2021 | |
| Astellas Pharma US INC | $134.11 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $72.79 | 2021 | |
| Pfizer INC. | $68.98 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $59.90 | 2021 | |
| Amarin Pharma, INC. | $56.74 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $49.85 | 2021 | |
| Amgen INC. | $44.09 | 2021 | |
| Esperion Therapeutics, INC. | $32.81 | 2021 | |
| Allergan, INC. | $22.05 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $18.75 | 2021 | |
| Eisai INC. | $11.80 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jocybel Itorralba listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.